Brain-Targeted Drug Delivery
At present, brain diseases affect one in six people worldwide, and they include a wide range of neurological diseases from Alzheimer’s and Parkinson’s diseases to epilepsy, brain injuries, brain cancer, neuroinfections and strokes [...]
Main Author: | Flávia Sousa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/9/1835 |
Similar Items
-
Nanotechnology in Targeted Drug Delivery
by: Antonio Di Stefano
Published: (2023-05-01) -
Mitochondria-Targeted Drug Delivery
by: Joanna Kopecka
Published: (2022-01-01) -
Advances in Mitochondria-Targeted Drug Delivery
by: Emanuela Bottani, et al.
Published: (2023-08-01) -
Smart Nanovesicles for Drug Targeting and Delivery
by: Carlotta Marianecci, et al.
Published: (2019-03-01) -
Advanced Blood–Brain Barrier Drug Delivery
by: William M. Pardridge
Published: (2022-12-01)